https://orthotw.com/2026/10/j-j-and-smith-nephew-had-a-34-billion-ortho-deal-on-the-table-then-they-couldn-t-agree-on-a-ceoOrthopedics This Weeken2026-10-23T13:56:00.000ZJ&J and Smith+Nephew Had a $34 Billion Ortho Deal on the Table. Then They Couldn’t Agree on a CEO. https://orthotw.com/2026/10/dr-kenneth-pettine-ceo-of-direct-regeneration-unveils-breakthrough-regenerative-technologies-set-to-disrupt-orthopedics-pain-management-and-skincareOrthopedics This Weeken2026-10-23T11:37:00.000ZDr. Kenneth Pettine, CEO of Direct Regeneration, Unveils Breakthrough Regenerative Technologies Set to Disrupt Orthopedics, Pain Management, and Skincare https://orthotw.com/2026/10/dual-mobility-hips-more-stability-a-fracture-trade-offOrthopedics This Weeken2026-10-22T13:38:00.000ZDual-Mobility Hips: More Stability, a Fracture Trade-Off? https://orthotw.com/2026/10/dair-to-be-selective-keeping-the-implant-doesn-t-mean-keeping-every-partOrthopedics This Weeken2026-10-22T12:55:00.000ZDAIR to Be Selective: Keeping the Implant Doesn’t Mean Keeping Every Part https://orthotw.com/2026/10/aclarion-announces-new-real-world-publication-nociscan-validated-by-strong-agreement-with-discography-in-diagnosing-painful-lumbar-discsOrthopedics This Weeken2026-10-22T11:49:00.000ZAclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs https://orthotw.com/2026/10/integra-lifesciences-reports-third-quarter-2026-financial-resultsOrthopedics This Weeken2026-10-22T01:07:00.000ZIntegra LifeSciences Reports Third Quarter 2026 Financial Results